KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Change in Cash: 2020-2025

Historic Change in Cash for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to -$94.4 million.

  • Ginkgo Bioworks Holdings' Change in Cash rose 17.35% to -$94.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$504.6 million, marking a year-over-year decrease of 16.51%. This contributed to the annual value of -$383.8 million for FY2024, which is 1.01% down from last year.
  • As of Q3 2025, Ginkgo Bioworks Holdings' Change in Cash stood at -$94.4 million, which was up 9.29% from -$104.1 million recorded in Q2 2025.
  • Ginkgo Bioworks Holdings' Change in Cash's 5-year high stood at $1.5 billion during Q3 2021, with a 5-year trough of -$250.3 million in Q1 2025.
  • Over the past 3 years, Ginkgo Bioworks Holdings' median Change in Cash value was -$104.1 million (recorded in 2025), while the average stood at -$110.2 million.
  • Its Change in Cash has fluctuated over the past 5 years, first surged by 113.96% in 2022, then slumped by 536.35% in 2023.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Change in Cash (Quarterly) stood at -$172.4 million in 2021, then surged by 113.96% to $24.1 million in 2022, then tumbled by 536.35% to -$105.0 million in 2023, then soared by 46.88% to -$55.8 million in 2024, then climbed by 17.35% to -$94.4 million in 2025.
  • Its last three reported values are -$94.4 million in Q3 2025, -$104.1 million for Q2 2025, and -$250.3 million during Q1 2025.